This prospective, multicentre, nasal carriage study in Chinese children with upper respiratory infection was carried out over the period from 2000 to 2002. Overall, the prevalence of pneumococcal carriage was 24.9%. Antimicrobial susceptibility tests were performed for 887 isolates of Streptococcus pneumoniae of which 33.5% were intermediately susceptible to penicillin and 6.4% were resistant. Multidrug resistance was very common. Pneumococcal strains (n = 625) were serotyped, showing 72.2% were covered by the 23-valent pneumococcal polysaccharide vaccine and 57.6% by the seven-valent pneumococcal conjugate vaccine. Serogroups 19 and 23 were significantly associated with penicillin resistance, which is increasing in China. Erythromycin, tetracycline and sulphamethoxazole/trimethoprim cannot be recommended as first-line treatments for respiratory tract infection as in some other developing countries. These features of serotype distribution are of importance for surveillance in the era of the new conjugate vaccine. In particular, these features will allow for documentation of serotype replacement after the introduction of widespread vaccination.
Introduction
Streptococcus pneumoniae remains the leading cause of community-acquired respiratory infections (CARI), such as pneumonia, otitis media, and paranasal sinusitis, and one of the most important human pathogens that causes severe invasive infections (e.g. meningitis and sepsis), 1,2 especially for children. At the same time, the increasing frequency and rapid spread of antimicrobial resistant pneumococcal strains is a global problem. The infecting pathogen is often unknown in the early phase of infection; thus, therapy is empirical. Furthermore, the choice of drug should reflect the local resistance profile. 3 In addition, the introduction of pneumococcal vaccines must be based on sufficient and timely information about capsular serotype distribution in the population. However, little information is available concerning antibiotic resistance and the capsular serotype distribution of pneumococcus, especially for those isolates taken from children in China.
Surveillance of S. pneumoniae should include invasive and non-invasive pneumococcal infections. However, documentation of invasive pneumococcal infections is relatively rare and pathogen cultures are rarely positive because of antibiotics abuse in China. 4 Pneumococcal diseases often follow nasopharyngeal carriage; the antimicrobial susceptibility profile of these isolates can be used as an estimate of the incidence of resistance in systemic isolates. 5, 6 Nasopharyngeal carriage of penicillin-resistant pneumococci in children could also reflect antimicrobial uses, with regard to both individual use and total consumption in the community. 7, 8 In 1996, the Centers for Disease Control and Prevention (CDC) 9 recommended that nasopharyngeal isolates could be used for surveillance of pneumococcal epidemiology since they can be obtained in higher numbers than invasive isolates.
In the present study, conducted from 2000 to 2002, an established multicentre surveillance network was used to evaluate the antimicrobial resistance, prevalence and serotype distribution in nasopharyngeal samples collected from out-patients with CARI in mainland China.
Materials and methods

PARTICIPATING CENTRES
From 2000 to 2002, the following three centres, located in different parts of mainland China, took part in the study: Beijing Children's Hospital, Beijing (BCH); Shanghai Children's Hospital, Shanghai (SCH) and Guangzhou Children's Hospital, Guangzhou (GCH). These three cities are located in the north, east and south of China, respectively. Samples were collected between February and May in each study year. In January 2000, all practitioners in the study were trained at BCH, to enable them to apply the same criteria to the study population and to standardize the procedures for sample collection, bacterial culture and testing for antibiotic susceptibility.
STUDY POPULATION
Children < 5 years old, with acute respiratory infections, who were attending an out-patient department were enrolled in the study. Children who had recently been hospitalized, those with known immunologic disorders, congenital diseases and current or recent invasive infection (such as acute respiratory infection [pneumonia], meningitis and bacteraemia), and children whose parents refused to allow them to be enrolled in the study were excluded. Consent to participate in the study was given by the children's parents and the study was approved by the Ethics Committee of BCH.
MICROBIOLOGICAL METHODS
Nasopharangeal secretions were collected from children using calcium alginate fibretipped ultrafine aluminium applicator swabs (Fisherband ® , Fisher Scientific, Fisher HealthCare, Houston, Texas, USA). The swabs were immediately placed in transport medium consisting of a solution of 2 g skimmed milk, 0.5 g glucose, 10 ml glycerol and 100 ml water K Yao, X Shen, S Yu et al. Antimicrobial resistance of S. pneumoniae in acute respiratory infection to make a uniform suspension (as recommended by Dr Orin Levine, CDC, USA, [personal communication]). Samples were sent to a local laboratory within 3 h. Cultures were grown on tryptone soy agar plates with 5% sheeps blood containing 5 µg/ml gentamicin. The plates were incubated at 35°C in a 5% CO 2 incubator and examined after 24 -48 h. Colonies typical for pneumococci were sub-cultured and identified by the optochin disk (BBL TM , Becton, Dickinson and Co., Sparks, USA) and bilesolubility tests. 8 For all isolates, minimum inhibitory concentrations (MICs) were determined against penicillin (PEN), amoxicillin/ clavulanic acid (AMC-CLV), ceftriaxone (CRO), cefuroxime (CXM), cefaclor (CEC), and erythromycin (ERY), by use of the E-test (Etest ® , AB Biodisk, Solna, Sweden). 10 All isolates were also tested against tetracycline (TET) and sulphamethoxazole/trimethoprim (SXT), and some of them against chloramphenicol (CHL) and ciprofloxacin (CIP), by the disk diffusion method using an antimicrobial disk (BD BBL TM Secsi-Disc TM , Becton, Dickinson and Co., Sparks, USA), according to performance standards of the National Committee for Clinical Laboratory Standards (NCCLS). 11 The Quellung reaction was performed using a simple chessboard typing system, based on 12 pooled antisera (pools A to F plus H, together with P to T). 13 A Pneumotest-kit was used, obtained from the Statenserum Institut, Copenhagen, Denmark. Twenty-one serogroups and/or serotypes could be identified by the system and this covered all serotypes presenting in the 23-valent (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F) pneumococcal polysaccharide vaccine currently in use in China for adult inoculation. The type or group was established from the reaction pattern by the use of a table with the types and groups entered in a rectangular chessboard arrangement. 13 Typing was done, as described in the literature, 13 by use of phase contrast (Olympus CX41RF, Olympus Corp., Tokyo, Japan), with an oil immersion lens (magnification, × 100).
STATISTICAL ANALYSIS
All data were sent to the laboratory at the BCH and were analysed with WHONET 5.3 software recommended by the World Heath Organization. The χ 2 test was performed to compare proportions, using SPSS ® version 10.0 software (SPSS Inc., Chicago, Illinois, USA). A two-tailed cut-off of P < 0.05 was considered a statistically significant difference.
Results
CARRIAGE RATES FOR PNEUMOCOCCI
In total 892 isolates of pneumococcus were recovered from nasopharyngeal swab specimens from 3578 children in three centres. Overall prevalence of carriage was 24.9%. The number of enrolled children and isolates contributed by the three centres are 
ANTIMICROBIAL SUSCEPTIBILITY RATES
Eight antimicrobial susceptibility tests were performed for 887 (99.4%) isolates of pneumococci (five of the strains died before testing) ( Table 1 ). Of these, 634 isolates were also tested for antimicrobial susceptibility to CHL, and 199 to CIP (Tables 2 and 3) .
Overall, 533 isolates (60.1%) were penicillin susceptible, 297 (33.5%) were intermediate, and 57 (6.4%) were resistant (Table 1 ). Of the other β-lactam antibiotics tested, AMC-CLV and CRO were the most active against pneumococcus (susceptibility rates: 98.5% and 97.2%, respectively), followed by CXM and CEC (80.9% and 76.0%, respectively). The The number and percentage of isolates non-susceptible to different β-lactam antibiotics varied by centre (Tables 1 and 2 ). For penicillin, Guangzhou ranked first in 2000 with 62.8% of the isolates not susceptible; the percentage of non-susceptible isolates decreased with time to 60% in 2001 and to 36% in 2002. Non-susceptible isolates in Beijing ranked last in 2000 (22%) and followed no apparent pattern in the following 2 years (29% and 18%, respectively). The prevalence in Shanghai was intermediate, except in 2002 when up to 61% of pneumococci were non-susceptible to penicillin. Overall, the resistance rates for CRO, CXM and CEC were lowest in Beijing, at < 10% for each of the three drugs tested over the 3 years. The highest resistant rates for CXM and CEC were in Guangzhou (10.8% and 39.2%, respectively).
Overall, non-susceptibility rates for the isolates of pneumococcus collected in 2000, 2001 and 2002 were > 80% for ERY, TET and SXT (Tables 2 and 3 ). There were no significant variations between centres and years. CHL resistance ( Table 2 and 3) was less common (16 -43%) than for the other nonβ-lactam antimicrobials, with the exception of CIP with a resistance rate of 1.0%.
Results of susceptibility tests of pneumococcal isolates to other antibiotics divided according to penicillin and erythromycin susceptibility are shown in Table 4 . Antimicrobial resistance was significantly associated (P < 0.001) with penicillin resistance, with the exception of TET and CHL, and was also significantly associated (P < 0.05) with erythromycin resistance, with the exception of AMC-CLV and CRO.
Multidrug resistance rates of pneumococcal isolates are shown in Table 4 . Significant differences (P < 0.001) were found not only between penicillin-susceptible (78.8%) and non-susceptible isolates (99.1%), but also between erythromycin-susceptible (17.1%) and non-susceptible isolates (95.8%).
SEROGROUP DISTRIBUTION
There were 625 pneumococcal strains typed. Serogroup 19 was the most frequent serogroup observed (19.4%, Table 5 ). Other frequently observed serogroups/serotypes, in 
Discussion
The present study is the first multicentre collaborative study and also the largest study of any kind to survey the resistance of pneumococcus isolated from Chinese children with upper respiratory infections, with up to 3578 children being involved during the 3 years of monitoring. The prevalence of pneumococcal nasopharyngeal carriage rates in children ranged from a high of 36.0% in Beijing in 2000, to a low of 13.5% in Guangzhou in the same year. The mean carriage rate was 24.9%, which is similar to the ANSORP study 8 and is slightly lower than in previous reports from other parts of the world. 1,8,14 -16 This study demonstrated that, overall, the prevalence of PNSP and PRSP was 39.9% and 6.4%, respectively. Widely different levels of penicillin resistance have been found in clinical and invasive pneumococcus isolates in different countries and areas. In studies conducted in the 1990s, PRSP rates were > 20% in Korea, 17, 18 Taiwan 18 and Hong Kong; 19 5 -20% in Singapore 20 and Australia; 21 < 5% in Japan, 22 Bangladesh 23 and Malaysia; 24 and 0% in Pakistan, 25 The Philippines 26 and India. 27 Analysis of data from some European countries, South Africa and the USA showed that about half the pneumococcal isolates from clinical specimens were not susceptible to penicillin. 28, 29 Although the rate of PNSP in our survey was relatively low, alarming levels of PNSP occurred in recent years in regions surrounding mainland China, including Korea (85.8%), Taiwan (91.3%), Sri Lanka (76.5%), Vietnam (70.4%) and Hong Kong (51.3%). 8, 30 Our findings indicate that penicillin non-susceptibility is highest in the The incidence of PNSP or PRSP changed differently among the three regions over the 3 years of the study. The present study showed that the penicillin resistance rate was relatively low in Beijing (22.9%), which was considerably lower than in neighbouring Asian countries and many other areas. Nevertheless, compared with reports from the 1990s, 8, 31 this was still an alarming increase. For example, of the 244 nasopharyngeal strains isolated from children in 1997, 32 (13.1%) were intermediate and 3 (1.2%) were resistant to penicillin. 31 In the ANSORP project, 8 of the 100 children carriage strains isolated in 1999, 13.4% were intermediate and none was resistant to penicillin.
Consistent with other studies, susceptibility patterns in the present study demonstrated that the majority of strains showing intermediate resistance to penicillin retained full susceptibility to AMC-CLV and cephalosporin, especially for CRO. It is worth noting that, in recent years, there has been a distinct growth in the number of strains that are very highly-resistant to CEC and CXM. CEC is a common, orally-administered agent for children in China, while CXM is administered by injection. In an investigation of the drugs used at the BCH in the years 1996 -2001, both were usually ranked in the first 15 most commonly-used drugs. 32 The investigation also showed that cephalosporins (ceftizoxime CXM and CRO) were commonly used with, in fact, first and second places usually occupied by cephalosporins. It may be that several high CEC-, CXM-or CRO-resistant strains with intermediate resistance to penicillin were isolated in the present study because of this pattern of antibiotic use.
In our study, resistance to ERY, TET and SXT was significantly higher (70 -90%) than for many European countries, Asian countries and the USA. 8, 33 Increasing use of macrolides (e.g. azithromycin) in the treatment of paediatric patients may be the main contributor to the increased prevalence of macrolide resistance, 32 along with inappropriate or overuse of these drugs. ERY-resistant pneumococci in China usually contain the resistant ermB gene (97.3%), which gives bacteria potent resistance compared with the mefA gene. 34 Prescriptions of SXT are decreasing in China and TET has not been used as a therapeutic agent in children for the past two decades. One explanation for higher resistance to these two antibiotics is possibly due to overuse in animals. Around 30% of the strains were resistant to CHL, which was used commonly during the 1970s and early 1980s, but is not in common use today. Multidrug resistance was very common in our study, especially amongst penicillin and ERY non-susceptible strains. Strains showing multi-drug resistance to ERY, TET, and SXT were very common in our study and this is consistent with other reports. 31 The serogroup/serotype distribution study showed serogroups 19, 23, 6, 14 and 15 were the most frequent. About 72.2% of all isolates were covered by the 23-valent polysaccharides vaccine, but no more than 57.6% of them were covered by the sevenvalent conjugate vaccine. The seven-valent pneumococcal conjugate vaccines Prevnar ® (Wyeth Vaccines, Collegeville, Pennsylvania, USA) and Prevenar ® (Wyeth-Lederle Vaccines, Pearl River, NY, USA) have been approved by the Food and Drug Administration (USA) K Yao, X Shen, S Yu et al. Antimicrobial resistance of S. pneumoniae in acute respiratory infection and the Committee on Proprietary Medicinal Products (Europe) for the prevention of invasive diseases in infants and young children 35, 36 . These vaccines have a potential coverage of over 85% of the pneumococcal isolates for the USA, 60 -70% for Europe and around 55% for Asia. 37 Our present study showed a similar result. We noticed, however, that there was a significant increase in the number of isolates belonging to serotypes covered by the seven-valent vaccine: from about 33.9% in 1997 38 to about 57.6% in the present study, mainly related to an increase in the frequency of serogroup 19 isolates: from about 7.4% in 1997 38 to 19.4% in this study. The sevenvalent vaccine coverage rates in Shanghai and Guangzhou, in the east and south of China, respectively, were higher than in Beijing. Because serogroups 19 and 23 were significantly associated with PNSP, the sevenvalent conjugate vaccine could cover more isolates in PNSP (194/265, 73.2%) than in PSSP (166/360, 61.9%) These results favour controlling antimicrobial resistance by extending immunization. 39 In China, management of childhood acute respiratory tract infections relies mainly on empirical antibiotic use. Abuse of antibiotics is very common and severely problematic, 4 therefore monitoring antibiotic resistance at local and national levels is of great importance when creating and modifying guidelines 40 for clinic practice. According to our results, special attention should be paid to the fact that PNSP and PRSP are increasing in China. Since resistance rates are amongst the highest in the world, ERY, TET and SXT cannot be recommended as a first-line treatment for respiratory tract infection, unlike in some other developing countries. It is important that these features of serotype distribution undergo surveillance in the era of the new conjugate vaccine. In particular, they will allow for documentation of serotype replacement after the introduction of widespread vaccination.
